Literature DB >> 1640031

Nosocomial pneumonia: epidemiology and infection control.

D E Craven1, K A Steger, L M Barat, R A Duncan.   

Abstract

Elderly, debilitated, or critically ill patients are at high risk for hospital acquired or nosocomial respiratory tract infection. Gram-negative bacilli, Staphyloccoccus aureus, and anaerobes colonizing the oropharynx are the most frequent etiologic agents. Colonization of the oropharynx may be related to the patient's age, underlying disease, nutritional status, prior exposure to antibiotics, supine position, and gastric colonization. Nosocomial pathogens may also be acquired from the hands of hospital personnel, contaminated equipment or fluids. The absence of sensitive and specific methods for accurate diagnosis remain a concern. Despite treatment with appropriate antimicrobial therapy, there is a high mortality and morbidity. Measures for the prevention of nosocomial pneumonia should include compliance with infection control principles, appropriate use of antibiotics, proper patient position, and removal of potential sources of cross colonization.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1640031     DOI: 10.1007/bf01752970

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  60 in total

1.  THE POTENTIAL ROLE OF INHALATION THERAPY EQUIPMENT IN NOSOCOMIAL PULMONARY INFECTION.

Authors:  J A REINARZ; A K PIERCE; B B MAYS; J P SANFORD
Journal:  J Clin Invest       Date:  1965-05       Impact factor: 14.808

2.  The gut origin septic states in blunt multiple trauma (ISS = 40) in the ICU.

Authors:  J R Border; J Hassett; J LaDuca; R Seibel; S Steinberg; B Mills; P Losi; D Border
Journal:  Ann Surg       Date:  1987-10       Impact factor: 12.969

3.  Bedside resuscitation bags: a source of bacterial contamination.

Authors:  A C Thompson; B J Wilder; D J Powner
Journal:  Infect Control       Date:  1985-06

Review 4.  Bacterial adherence to respiratory tract mucosa--a dynamic interaction leading to colonization.

Authors:  H Y Reynolds
Journal:  Semin Respir Infect       Date:  1987-03

5.  Stomach as source of bacteria colonising respiratory tract during artificial ventilation.

Authors:  S T Atherton; D J White
Journal:  Lancet       Date:  1978-11-04       Impact factor: 79.321

6.  Complications occurring during enteral nutrition support: a prospective study.

Authors:  E L Cataldi-Betcher; M H Seltzer; B A Slocum; K W Jones
Journal:  JPEN J Parenter Enteral Nutr       Date:  1983 Nov-Dec       Impact factor: 4.016

7.  Contaminated medication nebulizers in mechanical ventilator circuits. Source of bacterial aerosols.

Authors:  D E Craven; D A Lichtenberg; T A Goularte; B J Make; W R McCabe
Journal:  Am J Med       Date:  1984-11       Impact factor: 4.965

8.  Pulmonary function in mechanically-ventilated patients during 24-hour use of a hygroscopic condensor humidifier.

Authors:  N R MacIntyre; H R Anderson; R M Silver; F R Schuler; R E Coleman
Journal:  Chest       Date:  1983-11       Impact factor: 9.410

Review 9.  Hospital-acquired pneumonia: overview of the current state of the art for prevention and control.

Authors:  R P Wenzel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-01       Impact factor: 3.267

10.  Role of gastric colonization in nosocomial infections and endotoxemia: a prospective study in neurosurgical patients on mechanical ventilation.

Authors:  P Reusser; W Zimmerli; D Scheidegger; G A Marbet; M Buser; K Gyr
Journal:  J Infect Dis       Date:  1989-09       Impact factor: 5.226

View more
  9 in total

1.  Cross-colonisation with Pseudomonas aeruginosa of patients in an intensive care unit.

Authors:  D C Bergmans; M J Bonten; F H van Tiel; C A Gaillard; S van der Geest; R M Wilting; P W de Leeuw; E E Stobberingh
Journal:  Thorax       Date:  1998-12       Impact factor: 9.139

2.  Scoring system for nosocomial pneumonia in ICUs.

Authors:  A Kropec; G Schulgen; H Just; K Geiger; M Schumacher; F Daschner
Journal:  Intensive Care Med       Date:  1996-11       Impact factor: 17.440

3.  Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis.

Authors:  C Jaccard; N Troillet; S Harbarth; G Zanetti; D Aymon; R Schneider; R Chiolero; B Ricou; J Romand; O Huber; P Ambrosetti; G Praz; D Lew; J Bille; M P Glauser; A Cometta
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

4.  Rapid identification of Staphylococcus aureus in bronchoalveolar lavage fluid using a DNA probe (Accuprobe).

Authors:  B Allaouchiche; H Meugnier; J Freney; J Fleurette; J Motin
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

5.  Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults.

Authors:  Coleman Rotstein; Gerald Evans; Abraham Born; Ronald Grossman; R Bruce Light; Sheldon Magder; Barrie McTaggart; Karl Weiss; George G Zhanel
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-01       Impact factor: 2.471

Review 6.  Oral care measures for preventing nursing home-acquired pneumonia.

Authors:  Chang Liu; Yubin Cao; Jie Lin; Linda Ng; Ian Needleman; Tanya Walsh; Chunjie Li
Journal:  Cochrane Database Syst Rev       Date:  2018-09-27

7.  BAL for pneumonia prevention in tracheostomy patients: A clinical trial study.

Authors:  Amir K Vejdan; Maliheh Khosravi
Journal:  Pak J Med Sci       Date:  2013-01       Impact factor: 1.088

8.  Predicting nosocomial lower respiratory tract infections by a risk index based system.

Authors:  Yong Chen; Xue Shan; Jingya Zhao; Xuelin Han; Shuguang Tian; Fangyan Chen; Xueting Su; Yansong Sun; Liuyu Huang; Hajo Grundmann; Hongyuan Wang; Li Han
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

9.  Early-onset ventilator-associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment.

Authors:  Gilles Capellier; Hélène Mockly; Claire Charpentier; Djillali Annane; Gilles Blasco; Thibault Desmettre; Antoine Roch; Christophe Faisy; Joel Cousson; Samuel Limat; Mariette Mercier; Laurent Papazian
Journal:  PLoS One       Date:  2012-08-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.